Livforsakringsbolaget Skandia Omsesidigt Cuts Stock Position in Moderna, Inc. (NASDAQ:MRNA)

Livforsakringsbolaget Skandia Omsesidigt lessened its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 84.1% during the 4th quarter, Holdings Channel.com reports. The firm owned 733 shares of the company’s stock after selling 3,867 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Moderna were worth $73,000 as of its most recent SEC filing. Other […]

Related Keywords

Canada ,United States ,William Blair ,Noubar Afeyan ,Livforsakringsbolaget Skandia Omsesidigt ,Holdings Channel ,Royal Bank ,Nasdaq ,Invesco Ltd ,Jefferies Financial Group ,International Assets Investment Management ,Canaccord Genuity Group ,Investment Management ,Moderna Inc ,Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet ,Free Report ,Skandia Omsesidigt ,Assets Investment Management ,Hishtalmut Le Morim Tichoniim Havera Menahelet ,Get Free Report ,Financial Group ,Genuity Group ,Director Noubar Afeyan ,Shannon Thyme Klinger ,Visit Holdingschannel ,Moderna Daily ,Moderna ,Nasdaq Mrna ,Mrna ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,